Betty Wright Email & Phone Number

Florida, United States

• Successfully launched a new dual mechanism SGLT inhibitor, INPEFA, to Cardiologist and Interventional Cardiologist in the South Florida Market
• Top 3% sales attainment in the first-year post launch 2023
• Top 10% sales attainment YTD July 2024
• Created and executed a strategic plan based on skilled analysis of the current SGLT inhibitor market and current opportunities.
• Leveraged resources on specific targeted accounts that ensured early adoption of my product.
• Built success through strong collaboration with my internal colleagues and with my customers (physicians, nurses, and their staff)

Michigan, United States

Successful in leading the capital raise of $1M for the Launch and Development of medical devices in the Interventional Cardiology Space. Initiated and organized meetings with investors (Interventional Cardiologists, Angels, VC's) and "pitched" the “Investment opportunity.” Analyzed and conducted market research for the preparation of the Due Diligence.

Michigan, United States

Miami/Fort Lauderdale Area

• Was recruited to develop an under-performing territory from the ground up and made a quick positive impact in the first year. Consistently grew the business year after year making the territory # 5 in the Nation and in.
• Built relationships with key physician champions, nurses and pharmacists to help drive formulary approval and expand the use of my drugs
• Conducted in-services in the CVICU, ED, OR and CATH LABS that served to educate nurses and physicians on the drugs
• Customer include: CT Surgeons, CV Surgeons, Interventional Cardiologist, Neuro- Interventionalist, Neurologist, clinical pharmacist, pharmacy directors, nurse educators, stroke teams, Department Heads, Cath lab teams.
• Disease state focus: PCI, high risk PCI, ACS, STEMI, NSTEMI, Ischemic stroke, hemorrhagic stroke, Hypertensive emergencies, peri-procedural blood pressure management, carotid endarterectomy, aortic dissection and.

South Florida (Miami Dade County, Broward County, Palm Beach County)

ACHIEVEMENTS2016 Leading the Florida region in growth for our unique PCSK9 inhibitor Praluent. Responsible for launching Praluent, the First and only FDA approved PCSK9 Inhibitor. Biologic injection, a human monoclonal antibody 2014 BEST YTD Performance for Multaq sales in the Florida district 2012 "National Sales Champion Award" for sales success with.

South Florida

-Achieved the Pinnacle Award in 2002. Ranked top 5% of sales performers in the United States for sales of Plavix (anti-platelet) and Pravachol (statin). Cardiology focus-Successfully led the Miami District to #1 in the nation with Tequin (antibiotic) market share.-Successfully planned and executed a new product launch (Tequin) and achieved formulary.

South Florida

-Achieved top sales ranking for Zyprexa new prescriptions in the Florida region.-Solely managed Eli Lilly's neuroscience specialty sales division in the South Florida area. -Successfully promoted and sold Prozac and Zyprexa to key psychiatrists and neurologists

-Represented Ortho-McNeil's anti-infective and CNS sales division in the South Miami and Florida Keys territories.-Successful in selling Levaquin to both IM's and infectious disease specialist.

Bachelor Of Science

Managing And Motivating Talent Certificate

Education record